Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
Humalog save search
SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)
Published: 2024-04-17 (Crawled : 10:00) - prnewswire.com
SOPH | $5.01 -0.99% -1.0% 11K
|
|
| O: 3.2%
H: 0.0%
C: -3.0%
technology
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
Published: 2024-03-25 (Crawled : 00:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
million
SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada
Published: 2024-03-20 (Crawled : 20:00) - biospace.com/
SOPH | $5.01 -0.99% -1.0% 11K
|
|
| O: 0.0%
H: 10.28%
C: 5.78%
first canada
HOMOLOGY MEDICINES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX
Published: 2024-01-27 (Crawled : 08:20) - prnewswire.com
EGLE | $62.6 0.0% 2.9M
|
Transportation
| Email alert
Add to watchlist
alert
Q32 Bio and Homology Medicines Announce Merger Agreement
Published: 2023-11-16 (Crawled : 12:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 3.37%
H: 1.29%
C: 1.29%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.54%
H: 0.0%
C: 0.0%
agreement
Mucopolysaccharidosis Market to Accelerate Substantially, Predicts DelveInsight | Key Companies Working in the Market - Ultragenyx, Abeona, Homology, Denali, LYSOGENE, Allievex, Bellicum, Shire, Takeda
Published: 2023-08-01 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -2.23%
H: 0.0%
C: -0.56%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
SEEL | $0.2971 -9.17% -10.1% 600K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -1.27%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -2.64%
H: 0.0%
C: 0.0%
RGNX | $16.05 0.94% 0.93% 350K
|
Health Technology
|
| O: -0.52%
H: 1.65%
C: -0.79%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: -1.2%
H: 3.25%
C: 3.25%
DNLI | $15.55 -3.48% -3.6% 940K
|
Health Technology
|
| O: -1.2%
H: 0.0%
C: -1.5%
companies market
Biopharma Layoff Tracker 2023: Ribon, Homology, Mersana and More Cut Staff
Published: 2023-07-28 (Crawled : 15:00) - biospace.com/
VXRT | News | $0.7051 -5.41% -5.72% 1.5M
|
Health Technology
|
| O: 0.0%
H: 5.33%
C: 5.0%
TXMD | News | $1.88 -0.27% 15K
|
Health Technology
|
| O: 3.52%
H: 0.0%
C: -2.91%
PTCT | News S | $25.19 -0.87% -0.87% 560K
|
Health Technology
|
| O: 0.88%
H: 6.4%
C: 4.73%
NKTR | News | $1.39 -2.11% -2.16% 960K
|
Health Technology
|
| O: 0.2%
H: 7.65%
C: 6.65%
MOR | News | $18.07 0.17% 0.17% 130K
|
Health Technology
|
| O: 1.81%
H: 1.91%
C: 0.41%
AMRN | News | $0.8844 0.13% 0.12% 660K
|
Health Technology
|
| O: -0.44%
H: 5.31%
C: 5.31%
GOOGL | News 4 | $159.18 0.58% 0.58% 22M
|
Technology Services
|
| O: 1.07%
H: 2.26%
C: 1.38%
GOOG | News 4 | $161.05 0.71% 0.7% 19M
|
Technology Services
|
| O: 0.85%
H: 2.37%
C: 1.56%
OCX | News | $2.3 -6.31% -6.74% 41K
|
Health Technology
|
| O: 1.01%
H: 8.23%
C: 6.73%
biopharma
Biopharma Layoff Tracker 2023: Homology, Mersana, Biogen and More Cut Staff
Published: 2023-07-28 (Crawled : 13:00) - biospace.com/
VXRT | News | $0.7051 -5.41% -5.72% 1.5M
|
Health Technology
|
| O: 0.0%
H: 5.33%
C: 5.0%
TXMD | News | $1.88 -0.27% 15K
|
Health Technology
|
| O: 3.52%
H: 0.0%
C: -2.91%
PTCT | News S | $25.19 -0.87% -0.87% 560K
|
Health Technology
|
| O: 0.88%
H: 6.4%
C: 4.73%
NKTR | News | $1.39 -2.11% -2.16% 960K
|
Health Technology
|
| O: 0.2%
H: 7.65%
C: 6.65%
MOR | News | $18.07 0.17% 0.17% 130K
|
Health Technology
|
| O: 1.81%
H: 1.91%
C: 0.41%
AMRN | News | $0.8844 0.13% 0.12% 660K
|
Health Technology
|
| O: -0.44%
H: 5.31%
C: 5.31%
GOOGL | News 4 | $159.18 0.58% 0.58% 22M
|
Technology Services
|
| O: 1.07%
H: 2.26%
C: 1.38%
GOOG | News 4 | $161.05 0.71% 0.7% 19M
|
Technology Services
|
| O: 0.85%
H: 2.37%
C: 1.56%
OCX | News | $2.3 -6.31% -6.74% 41K
|
Health Technology
|
| O: 1.01%
H: 8.23%
C: 6.73%
biopharma
Inspira™ Technologies Announces First in Human of HYLA™ Blood Sensor in Clinical Study
Published: 2023-03-22 (Crawled : 15:00) - biospace.com/
IINN | $1.925 3.5% 3.38% 130K
|
Manufacturing
|
| O: -0.72%
H: 8.47%
C: 2.19%
blood sensor study
Lordstown Endurance™ Pickup Truck Achieves Full Homologation; EPA and CARB Certification Received; First Customer Vehicles Leaving Foxconn EV Ohio Plant for Delivery
Published: 2022-11-29 (Crawled : 13:00) - globenewswire.com
RIDE | $2.2 2.33% 2.71% 1.4M
|
Consumer Durables
|
| O: 5.62%
H: 0.0%
C: 0.0%
certification vehicles truck
Novavax COVID-19-Influenza Combination Vaccine Candidate Induced Antibody and T-Cell Responses Against SARS-CoV-2 and Homologous and Heterologous Influenza Strains
Published: 2022-10-13 (Crawled : 13:00) - prnewswire.com
NVAX | $4.15 -0.96% -0.96% 2.4M
|
Health Technology
|
| O: -5.01%
H: 13.34%
C: 10.69%
covid-19 candidate antibody vaccine t-cell sars-cov-2 influenza
Novavax Prototype COVID-19 Vaccine Data Support Homologous and Heterologous Boosting and Suggest Benefit Against Variants
Published: 2022-10-12 (Crawled : 13:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 1.29%
H: 0.0%
C: 0.0%
NVAX | $4.15 -0.96% -0.96% 2.4M
|
Health Technology
|
| O: 1.27%
H: 5.93%
C: 5.36%
covid-19 vaccine prototype
LYNPARZA® (olaparib) Approved in China as First-Line Maintenance Treatment With Bevacizumab for Homologous Recombination Deficient (HRD)-Positive Advanced Ovarian Cancer
Published: 2022-09-22 (Crawled : 11:00) - biospace.com/
FNCTF | News | $11.16 -20.84% 130
|
Communications
|
| O: 5.36%
H: 0.0%
C: -1.08%
MRK | $127.0 0.1% -1.21% 7.1M
|
Health Technology
|
| O: 0.02%
H: 4.26%
C: 3.5%
lynparza treatment approved china cancer ovarian cancer
Movers & Shakers: Homology Medicines, GlycoMimetics, MiMedx and More Tap New ...
Published: 2022-09-09 (Crawled : 14:00) - biospace.com/
EXAI | $4.15 -5.25% -5.54% 360K
|
|
| O: 0.64%
H: 0.0%
C: -5.05%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.13%
H: 1.81%
C: 1.26%
OCGN | News 4 | $1.17 -6.4% -6.84% 7.3M
|
Health Technology
|
| O: 0.82%
H: 1.62%
C: 0.4%
Clover’s COVID-19 Vaccine Candidate Demonstrates Strong Cross-Neutralization Against Omicron as a Homologous Booster
Published: 2022-06-27 (Crawled : 12:00) - biospace.com/
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: -0.24%
H: 3.41%
C: 1.63%
covid-19 candidate vaccine
Global Wireless Power Transmission Market (2022 to 2027) - Featuring Analog Devices, Emrod and Humavox Among Others
Published: 2022-06-02 (Crawled : 20:00) - prnewswire.com
RYLPF | $20.52 3.85% 110K
|
Health Technology
|
| O: -0.3%
H: 0.86%
C: -0.29%
market
Valneva Announces Positive Homologous Booster Data for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001
Published: 2021-12-16 (Crawled : 09:00) - biospace.com/
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: 5.3%
H: 3.56%
C: -1.05%
covid-19 valneva covid vla200 positive vaccine vla2001
INOVIO Announces Online Preprint Publication of Homologous Boosting Data for its COVID-19 DNA Vaccine Candidate, INO-4800
Published: 2021-10-12 (Crawled : 13:00) - inovio.com
INO | $10.1 -2.6% -2.67% 250K
|
Health Technology
|
| O: 2.06%
H: 0.58%
C: -0.29%
covid vaccine ino-4800
Homology Medicines Announces Promotion of Tim Kelly to Chief Operating Officer
Published: 2021-04-12 (Crawled : 13:00) - globenewswire.com
SRPT | $124.27 6.11% 5.75% 1.3M
|
Health Technology
|
| O: -0.17%
H: 0.4%
C: -1.48%
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.